Zapping AFib: new balloon device enters human testing
NCT ID NCT06828939
Summary
This is the first human study to test the safety and effectiveness of a new balloon device that uses pulsed electric fields to treat atrial fibrillation (AFib). The device aims to isolate the heart's pulmonary veins, which are often the source of AFib episodes. The study will enroll 75 people with short-duration, symptomatic AFib who haven't had a previous ablation and will follow them for one year after the procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PAROXYSMAL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Na Homolce Hospital
RECRUITINGPrague, Czech Republic, Czechia
Conditions
Explore the condition pages connected to this study.